Research ArticleSpecial Communication

Health Care for Patients with Serious Mental Illness: Family Medicine's Role

Nancy E. Morden, Lisa A. Mistler, William B. Weeks and Stephen J. Bartels
The Journal of the American Board of Family Medicine March 2009, 22 (2) 187-195; DOI: https://doi.org/10.3122/jabfm.2009.02.080059

References

  1. ↵
    National Heart Lung and Blood Institute. National Cholesterol Education Program Report. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines, 2004. Available at http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.pdf. Accessed 22 January 2008.
  2. ↵
    Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212–7.
    OpenUrlAbstract/FREE Full Text
  3. Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ 2000; 321: 483–4.
    OpenUrlFREE Full Text
  4. ↵
    Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123–31.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596–601.
    OpenUrlFREE Full Text
  6. ↵
    Goff DC. Integrating general health care in private community psychiatry practice. J Clin Psychiatry 2007; 68(suppl 4): 49–54.
    OpenUrlPubMed
  7. ↵
    Vreeland B. Bridging the gap between mental and physical health: a multidisciplinary approach. J Clin Psychiatry 2007; 68(suppl 4): 26–33.
    OpenUrlCrossRef
  8. ↵
    Narrow WE, Regier DA, Norquist G, Rae DS, Kennedy C, Arons B. Mental health service use by Americans with severe mental illnesses. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 147–55.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 1997; 171: 502–8.
    OpenUrlAbstract/FREE Full Text
  10. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006; 3: A42.
    OpenUrlPubMed
  11. ↵
    Hansen V, Jacobsen BK, Arnesen E. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry 2001; 179: 438–43.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Osby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000; 45: 21–8.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005; 150: 1115–21.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007; 64: 242–9.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005; 80: 45–53.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 2006; 86: 15–22.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Bartels SJ. Caring for the whole person: integrated health care for older adults with severe mental illness and medical comorbidity. J Am Geriatr Soc 2004; 52(12 Suppl): S249–57.
    OpenUrlCrossRefPubMedWeb of Science
  18. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis 2004; 192: 421–7.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844–50.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics 2007; 48: 412–7.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80: 19–32.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004; 6: 368–73.
    OpenUrlCrossRefPubMedWeb of Science
  23. Birkenaes AB, Opjordsmoen S, Brunborg C, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007; 68: 917–23.
    OpenUrlCrossRefPubMedWeb of Science
  24. Laursen TM, Munk-Olsen T, Nordentoft M, Mortensen PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 2007; 68: 899–907.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163: 183–9.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29: 697–701.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry 2006; 14: 212–22.
    OpenUrlCrossRefPubMedWeb of Science
  28. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004; 29: 1067–83.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 2606–10.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Wildes JE, Marcus MD, Fagiolini A. Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model. J Clin Psychiatry 2006; 67: 904–15.
    OpenUrlPubMed
  31. ↵
    McCreadie R, Macdonald E, Blacklock C, et al. Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. BMJ 1998; 317: 784–5.
    OpenUrlFREE Full Text
  32. ↵
    Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19(suppl 1): 1–93.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–96.
    OpenUrlPubMedWeb of Science
  34. ↵
    Meyer JM, Koro CE. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 2004; 70: 1–17.
    OpenUrlPubMedWeb of Science
  35. ↵
    Henderson DC, Cagliero E, Copeland PM, et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 2005; 62: 19–28.
    OpenUrlCrossRefPubMedWeb of Science
  36. Newcomer JW. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. J Clin Psychiatry 2004; 65(suppl 18): 36–46.
    OpenUrlPubMed
  37. ↵
    Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry 2001; 58: 565–72.
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000; 283: 506–11.
    OpenUrlCrossRefPubMedWeb of Science
  39. ↵
    Daumit GL, Pronovost PJ, Anthony CB, Guallar E, Steinwachs DM, Ford DE. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry 2006; 63: 267–72.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    Druss BG, Rosenheck RA, Desai MM, Perlin JB. Quality of preventive medical care for patients with mental disorders. Med Care 2002; 40: 129–36.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    Druss BG, Rohrbaugh RM, Levinson CM, Rosenheck RA. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry 2001; 58: 861–8.
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    Lester H, Tritter JQ, Sorohan H. Patients' and health professionals' views on primary care for people with serious mental illness: focus group study. BMJ 2005; 330: 1122.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Newcomer JW, Nasrallah HA, Loebel AD. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists. J Clin Psychopharmacol 2004; 24(5 suppl 1): S1–6.
    OpenUrlCrossRefPubMed
  44. ↵
    Grumbach K, Bodenheimer T. A primary care home for Americans: putting the house in order. JAMA 2002; 288: 889–93.
    OpenUrlCrossRefPubMedWeb of Science
  45. ↵
    Mechanic D. Approaches for coordinating primary and specialty care for persons with mental illness. Gen Hosp Psychiatry 1997; 19: 395–402.
    OpenUrlCrossRefPubMed
  46. ↵
    Alfano E. Integration of Primary Care and Behavioral Health: Report on a Roundtable Discussion of Strategies fro Private Health Insurance. In: Carty, L (ed.). Washington, DC: Bazelon Center for Mental Health Law; 2005.
  47. ↵
    Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002; 288: 1909–14.
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry 2007; 68(suppl 4): 40–4.
    OpenUrlPubMedWeb of Science
  49. ↵
    Golomb BA, Pyne JM, Wright B, Jaworski B, Lohr JB, Bozzette SA. The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv 2000; 51: 766–73.
    OpenUrlCrossRefPubMed
  50. ↵
    Druss BG, von Esenwein SA. Improving general medical care for persons with mental and addictive disorders: systematic review. Gen Hosp Psychiatry 2006; 28: 145–53.
    OpenUrlCrossRefPubMedWeb of Science
  51. ↵
    Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995; 273: 1026–31.
    OpenUrlCrossRefPubMedWeb of Science
  52. ↵
    Dietrich AJ, Oxman TE, Williams JW Jr, et al. Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial. BMJ 2004; 329: 602.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Koyanagi C. Get it together: how to integrate physical and mental health care for persons with serious mental illness. Washington, DC: Bazelon Center for Mental Health Law; 2004.
  54. ↵
    Griswold KS, Servoss TJ, Leonard KE, et al. Connections to primary medical care after psychiatric crisis. J Am Board Fam Pract 2005; 18: 166–72.
    OpenUrlCrossRefPubMed
  55. ↵
    Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R. Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multidisciplinary health intervention in a detoxification unit. Addiction 2003; 98: 509–16.
    OpenUrlCrossRefPubMed
  56. ↵
    National Association of State Mental Health Program Directors Medical Directors Council. Integrating behavioral health and primary care services: opportunities and challenges for state mental health authorities. Alexandria (VA): National Association of State Mental Health Program Directors; 2005.
  57. Doebbeling CC, Pitkin AK, Malis R, Yates WR. Combined internal medicine-psychiatry and family medicine-psychiatry training programs, 1999–2000: program directors' perspectives. Acad Med 2001; 76: 1247–52.
    OpenUrlPubMed
  58. ↵
    Bower P, Gilbody S. Managing common mental health disorders in primary care: conceptual models and evidence base. BMJ 2005; 330: 839–42.
    OpenUrlFREE Full Text
  59. ↵
    Seeman MV. An outcome measure in schizophrenia: mortality. Can J Psychiatry 2007; 52: 55–60.
    OpenUrlPubMedWeb of Science
  60. ↵
    Kritchevsky SB, Simmons BP. Continuous quality improvement. Concepts and applications for physician care. JAMA 1991; 266: 1817–23.
    OpenUrlCrossRefPubMedWeb of Science
  61. ↵
    Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatr Serv 1998; 49: 925–8.
    OpenUrlPubMedWeb of Science
  62. Addington J, el-Guebaly N. Group treatment for substance abuse in schizophrenia. Can J Psychiatry 1998; 43: 843–5.
    OpenUrlPubMed
  63. Addington J, el-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry 1998; 155: 974–6.
    OpenUrlPubMedWeb of Science
  64. Bartels SJ, Forester B, Mueser KT, et al. Enhanced skills training and health care management for older persons with severe mental illness. Community Ment Health J 2004; 40: 75–90.
    OpenUrlCrossRefPubMedWeb of Science
  65. Khazaal Y, Fresard E, Rabia S, et al. Cognitive behavioral therapy for weight gain associated with antipsychotic drugs. Schizophr Res 2007; 91: 169–77.
    OpenUrlCrossRefPubMed
  66. Chou KR, Chen R, Lee JF, Ku CH, Lu RB. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud 2004; 41: 321–30.
    OpenUrlCrossRefPubMed
  67. Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry 2005; 39: 479–86.
    OpenUrlCrossRefPubMedWeb of Science
  68. Hoffmann VP, Ahl J, Meyers A, et al. Wellness intervention for patients with serious and persistent mental illness. J Clin Psychiatry 2005; 66: 1576–9.
    OpenUrlPubMed
  69. Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh 2003; 35: 237–41.
    OpenUrlCrossRefPubMedWeb of Science
  70. Mauri M, Castrogiovanni S, Simoncini M, et al. Effects of an educational intervention on weight gain in patients treated with antipsychotics. J Clin Psychopharmacol 2006; 26: 462–6.
    OpenUrlPubMed
  71. Melamed Y, Stein-Reisner O, Gelkopf M, et al. Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J 2008; 31: 194–200.
    OpenUrlCrossRefPubMed
  72. Wu RR, Zhao JP, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008; 299: 185–93.
    OpenUrlCrossRefPubMedWeb of Science
  73. ↵
    Levine S, Unutzer J, Yip JY, et al. Physicians' satisfaction with a collaborative disease management program for late-life depression in primary care. Gen Hosp Psychiatry 2005; 27: 383–91.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section